Clinical update from a phase 1, first-in-human, open-label single agent study of suplexa therapeutic cells in patients with metastatic solid tumours and haematologic malignancies
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要